A deep understanding of the weight regulation mechanism and the impact of the gut-brain axis on appetite has spurred the development of incretin-based medications, such as GLP-1 receptor agonists
However, at that time, the molecular mechanism of the Nox3-derived ROS, which is responsible for otoconia formation, was pure speculation [370]
We used unpaired Students t test (two-tailed) and ANOVA to evaluate the statistical significance
Summary: GLP-1 medications may not work due to insufficient dosing, individual biological variation in receptor function, advanced beta cell dysfunction, lifestyle factors, or unrealistic expectations about treatment timelines and outcomes
In failing heart tissue, the uptake and metabolism of these substrates are compromised, reducing oxidative phosphorylation and energy production [54]